Samsung C&T (028260) Q4 2025 earnings summary

Executive summary

• 4Q25 sales reached KRW 10.8 tn, up KRW 681 bn QoQ and KRW 839 bn YoY; full-year 2025 sales were KRW 40.7 tn, down KRW 1.4 tn YoY.

• Net profit for 4Q25 was KRW 1.56 tn, up KRW 673 bn QoQ and KRW 902 bn YoY; full-year net profit rose KRW 1.1 tn YoY to KRW 3.9 tn.

• Operating profit for 4Q25 was KRW 822 bn, down KRW 172 bn QoQ but up KRW 187 bn YoY; OP margin improved YoY to 7.6%.

Financial highlights

• Gross profit for 4Q25 was KRW 2.08 tn, up KRW 31 bn QoQ and KRW 248 bn YoY.

• SG&A expenses increased to KRW 1.26 tn in 4Q25, up KRW 203 bn QoQ and KRW 61 bn YoY.

• Non-operating profit in 4Q25 was KRW 220 bn, up KRW 54 bn QoQ and KRW 83 bn YoY.

• Total assets at end-2025 were KRW 86.5 tn, up KRW 24.5 tn YoY; equity increased KRW 20.2 tn YoY to KRW 57.5 tn.

Outlook and guidance

• 2026 sales projected to increase YoY by strengthening and expanding a diversified business portfolio.

• E&C sales expected to rise on higher contributions from high-tech and secured projects; T&I to expand trading value chains.

• Bio segment to benefit from full-capacity operation of Plants 1-4 and increased biosimilar sales.

• Push to secure KRW 7.7 tn of construction rights in 2026.